ABCB1 polymorphism as a predictive biomarker for amrubicin-induced neutropenia
O Takakuwa, T Oguri, T Uemura, E Kunii… - Anticancer …, 2014 - ar.iiarjournals.org
Background: Amrubicin is a promising therapy for lung cancer, but is associated with a high
incidence of severe neutropenia. The present study assessed the utility of ABCB1 and NAD …
incidence of severe neutropenia. The present study assessed the utility of ABCB1 and NAD …
[PDF][PDF] ABCB1 Polymorphism as a Predictive Biomarker for Amrubicin-induced Neutropenia
O TAKAKUWA, T OGURI, T UEMURA… - ANTICANCER …, 2014 - ar.iiarjournals.org
Background: Amrubicin is a promising therapy for lung cancer, but is associated with a high
incidence of severe neutropenia. The present study assessed the utility of ABCB1 and NAD …
incidence of severe neutropenia. The present study assessed the utility of ABCB1 and NAD …
ABCB1 polymorphism as a predictive biomarker for amrubicin-induced neutropenia
O Takakuwa, T Oguri, T Uemura, E Kunii… - Anticancer …, 2014 - pubmed.ncbi.nlm.nih.gov
Background Amrubicin is a promising therapy for lung cancer, but is associated with a high
incidence of severe neutropenia. The present study assessed the utility of ABCB1 and NAD …
incidence of severe neutropenia. The present study assessed the utility of ABCB1 and NAD …
ABCB1 polymorphism as a predictive biomarker for amrubicin-induced neutropenia.
O Takakuwa, T Oguri, T Uemura, E Kunii… - Anticancer …, 2014 - europepmc.org
Background Amrubicin is a promising therapy for lung cancer, but is associated with a high
incidence of severe neutropenia. The present study assessed the utility of ABCB1 and NAD …
incidence of severe neutropenia. The present study assessed the utility of ABCB1 and NAD …